Innovation Showcase

SYNTHETIC PEPTIDE-BASED GROWTH FACTOR ALTERNATIVE AND THEIR APPLICATION

Conventional growth factors and cytokines used in the manufacturing of regenerative medicine and cell therapy products are facing various challenges such as lot-to-lot quality variations, potential contamination with biological impurities, low stability, and high manufacturing cost. PeptiGrowth Inc. has been working on the development of a series of synthetic peptides that have better qualities, activities and functions than conventional growth factors and cytokines, and that can address and solve all these challenges. These peptides are totally chemically synthesized and animal component-free. PeptiGrowth was established in April 2020 aiming to thoroughly solve these problems and to support the development of industry growth. The alternative peptide for HGF, BDNF, Noggin, VEGF, Wnt3a, EGF, TPO have been already launched in the market and some of their application examples to cell culture models are planned to be introduced in this presentation.